Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 6/20 | 0.76 |
| ▸ | MEN1 | O00255 | 1/20 | 0.76 |
| ▸ | ABL1 | P00519 | 1/20 | 0.76 |
| ▸ | LMNA | P02545 | 1/20 | 0.76 |
| ▸ | PKM | P14618 | 1/20 | 0.76 |
| ▸ | IDE | P14735 | 1/20 | 0.76 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.76 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.76 |
| ▸ | RIN1 | Q13671 | 1/20 | 0.76 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.76 |
| ▸ | HLCS | P50747 | 6/20 | 0.54 |
| ▸ | CA12 | O43570 | 5/20 | 0.46 |
| ▸ | CA1 | P00915 | 5/20 | 0.46 |
| ▸ | CA2 | P00918 | 5/20 | 0.46 |
| ▸ | CA9 | Q16790 | 5/20 | 0.46 |
| ▸ | PTPRF | P10586 | 2/20 | 0.44 |
| ▸ | PTPN2 | P17706 | 2/20 | 0.44 |
| ▸ | PTPN1 | P18031 | 2/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Biotin SCHEMBL2456558 | 1.00 | TDP1 (0.76) | TDP1MEN1ABL1LMNAPKM | |
| Biotin SCHEMBL9841217 | 0.87 | TDP1 (1.00) | TDP1MEN1ABL1LMNAPKM | |
| Biotin SCHEMBL410686 | 0.87 | TDP1 (1.00) | TDP1MEN1ABL1LMNAPKM | |
| Biotin SCHEMBL7697731 | 0.87 | TDP1 (1.00) | TDP1MEN1ABL1LMNAPKM | |
| Biotin SCHEMBL59420 | 0.87 | TDP1 (1.00) | TDP1MEN1ABL1LMNAPKM | |
| Biotin SCHEMBL23055065 | 0.87 | TDP1 (1.00) | TDP1MEN1ABL1LMNAPKM | |
| Biotin SCHEMBL21981206 | 0.87 | TDP1 (1.00) | TDP1MEN1ABL1LMNAPKM | |
| Biotin SCHEMBL22943835 | 0.87 | TDP1 (1.00) | TDP1MEN1ABL1LMNAPKM | |
| Biotin SCHEMBL20547409 | 0.87 | TDP1 (1.00) | TDP1MEN1ABL1LMNAPKM | |
| Biotin SCHEMBL36572 | 0.87 | TDP1 (1.00) | TDP1MEN1ABL1LMNAPKM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 32 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-105814213-B | Modified glycoproteins, protein-conjugates and methods of making the same | 西纳福克斯股份有限公司 | 2021-05-04 | — | — | CN | disclosed |
| US-20190307903-A1 | METHOD FOR MANUFACTURING A BIOCOMPATIBLE FLUID COMPRISING A POWDER OF MAGNETIC PARTICLES, BIOCOMPATIBLE FLUID COMPRISING A POWDER OF MAGNETIC PARTICLES | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) (FR) | 2019-10-10 | — | — | US | disclosed |
| EP-3549577-A1 | METHOD FOR MANUFACTURING A BIOCOMPATIBLE FLUID COMPRISING A MAGNETIC PARTICLE POWDER, BIOCOMPATIBLE FLUID COMPRISING A MAGNETIC PARTICLE POWDER | Commissariat à l'Energie Atomique et aux Energies Alternatives (FR) | 2019-10-09 | — | — | EP | disclosed |
| US-10081678-B2 | Specific binding antibodies of glycoprotein IB alpha as selective ectodomain shedding inhibitors | EMORY UNIVERSITY (US) | 2018-09-25 | — | — | US | disclosed |
| US-20160009801-A1 | SPECIFIC BINDING AGENTS OF GLYCOPROTEIN IB ALPHA AS SELECTIVE ECTODOMAIN SHEDDING INHIBITORS | EMORY UNIVERSITY | 2016-01-14 | — | — | US | disclosed |
| EP-2890788-A1 | BIOTIN COMPLEXES FOR TREATMENT AND DIAGNOSIS OF ALZHEIMER'S DISEASE | The General Hospital Corporation (US) | 2015-07-08 | — | — | EP | disclosed |
| WO-2014121176-A2 | SPECIFIC BINDING AGENTS OF GLYCOPROTEIN IB ALPHA AS SELECTIVE ECTODOMAIN SHEDDING INHIBITORS | EMORY UNIVERSITY (US) | 2014-08-07 | — | — | WO | disclosed |
| WO-2014036427-A1 | BIOTIN COMPLEXES FOR TREATMENT AND DIAGNOSIS OF ALZHEIMER'S DISEASE | THE GENERAL HOSPITAL CORPORATION (US) | 2014-03-06 | — | — | WO | disclosed |
| EP-1634077-A4 | MICROPOSITIONING CELLS FOR TISSUE ENGINEERING | UNIV TEXAS (US) | 2007-03-28 | — | — | EP | disclosed |
| WO-2006124726-A2 | NOVEL BIOTINYLATED COMPOSITIONS | THE GENERAL HOSPITAL CORPORATION (US) | 2006-11-23 | — | — | WO | disclosed |
| US-20020142389-A1 | Soluble T cell receptor | JAKOBSEN BENT KARSTEN (GB) | 2002-10-03 | — | — | US | disclosed |
| US-20020119149-A1 | Multivalent T cell receptor complexes | JAKOBSEN BENT KARSTEN (GB) | 2002-08-29 | — | — | US | disclosed |
| WO-2002058729-A2 | METHODS OF INDUCING ORGAN TRANSPLANT TOLERANCE AND CORRECTING HEMOGLOBINOPATHIES | EMORY UNIVERSITY (US) | 2002-08-01 | — | — | WO | disclosed |
| EP-1066380-B1 | SOLUBLE T CELL RECEPTOR | AVIDEX LTD (GB) | 2001-11-14 | — | — | EP | disclosed |
| EP-1080193-A2 | MULTIVALENT T CELL RECEPTOR COMPLEXES | Avidex, Ltd. (GB) | 2001-03-07 | — | — | EP | disclosed |
| EP-1066380-A2 | SOLUBLE T CELL RECEPTOR | Avidex Ltd. (GB) | 2001-01-10 | — | — | EP | disclosed |
| WO-1999060119-A2 | MULTIVALENT T CELL RECEPTOR COMPLEXES | AVIDEX, LTD. (GB) | 1999-11-25 | — | — | WO | disclosed |
| WO-1999060120-A2 | SOLUBLE T CELL RECEPTOR | AVIDEX LIMITED (GB) | 1999-11-25 | — | — | WO | disclosed |
| EP-0654061-A1 | A METHOD OF CHEMICAL COUPLING ON SOLID PHASES | MOURITSEN & ELSNER A/S (DE) | 1995-05-24 | — | — | EP | disclosed |
| WO-1994003530-A1 | A METHOD OF CHEMICAL COUPLING ON SOLID PHASES | MOURITSEN & ELSNER A/S (DK) | 1994-02-17 | — | — | WO | disclosed |